Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 25, 2021 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results

CARLSBAD, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
February 22, 2021 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis

CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...
February 16, 2021 17:35 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference

CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing...
February 16, 2021 16:03 ET | Source: GenMark Diagnostics, Inc.

Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels

CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today the...
February 16, 2021 16:03 ET | Source: GenMark Diagnostics, Inc.

L'étude souligne la valeur clinique potentielle des panels pour l'identification d'hémocultures ePlex®

CARLSBAD, Calif., 16 févr. 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ : GNMK), fournisseur de premier plan en matière de systèmes de tests de diagnostic moléculaire multiplex...
February 11, 2021 16:17 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

CARLSBAD, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter and full year earnings results after market...
January 11, 2021 16:08 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020

CARLSBAD, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
December 28, 2020 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing...
November 05, 2020 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum

CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing...
October 28, 2020 16:05 ET | Source: GenMark Diagnostics, Inc.

GenMark Diagnostics Reports Third Quarter 2020 Results

CARLSBAD, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...